Programmed death-1 (PD-1) and EBV-encoded RNA (EBER) expression in Hodgkin lymphoma.

被引：0
|
作者：
Paydas, Semra
Bagir, Emine
Ergin, Melek
Duman, Berna Bozkurt
Ercolak, Vehbi
机构：
[1] Cukurova Univ, Fac Med, Adana, Turkey
[2] Cukurova Univ, Adana, Turkey
[3] Cukurova Univ, Fac Med, Dept Pathol, Adana, Turkey
[4] Adana Numune Educ & Res Hosp, Adana, Turkey
[5] Cukurova Univ, Sch Med, Dept Med Oncol, Adana, Turkey
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.e19514
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19514
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Programmed Death-1 and Programmed Death-Ligand 1 Expression Patterns in Pediatric Lymphoma
    Tamura, Akihiro
    Yoshida, Makiko
    Yamamoto, Nobuyuki
    Nino, Nanako
    Nakatani, Naoko
    Ichikawa, Takayuki
    Nakamura, Sayaka
    Saito, Atsuro
    Kozaki, Aiko
    Kishimoto, Kenji
    Ishida, Toshiaki
    Hasegawa, Daiichiro
    Kosaka, Yoshiyuki
    BLOOD, 2018, 132
  • [22] Programmed death-1 (PD-1) polymorphism is associated with gastric cardia adenocarcinoma
    Tang, Weifeng
    Chen, Yu
    Chen, Shuchen
    Sun, Bin
    Gu, Haiyong
    Kang, Mingqiang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (05): : 8086 - 8093
  • [23] Nivolumab as Programmed Death-1 (PD-1) Inhibitor for Targeted Immunotherapy in Tumor
    Guo, Liting
    Zhang, Haijun
    Chen, Baoan
    JOURNAL OF CANCER, 2017, 8 (03): : 410 - 416
  • [24] Programmed death-1 (PD-1) polymorphisms in Chinese patients with esophageal cancer
    Qiu, Hao
    Zheng, Liang
    Tang, Weifeng
    Yin, Pengfei
    Cheng, Feng
    Wang, Lixin
    CLINICAL BIOCHEMISTRY, 2014, 47 (7-8) : 612 - 617
  • [25] Programmed death-1 (PD-1)-deficient mice are extraordinarily sensitive to tuberculosis
    Lazar-Molnar, Eszter
    Chen, Bing
    Sweeney, Kari A.
    Wang, Emilie J.
    Liu, Weijun
    Lin, Juan
    Porcelli, Steven A.
    Almo, Steven C.
    Nathenson, Stanley G.
    Jacobs, William R., Jr.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (30) : 13402 - 13407
  • [26] Treg suppressive activity involves estrogen-dependent expression of programmed death-1 (PD-1)
    Polanczyk, Magdalena J.
    Hopke, Corwyn
    Vandenbark, Arthur A.
    Offner, Halina
    INTERNATIONAL IMMUNOLOGY, 2007, 19 (03) : 337 - 343
  • [27] Clinical and histopathological significance of programmed death-1 (PD-1) expression in cutaneous lesions of adult T-cell leukemia lymphoma
    Nakashima, M. H.
    Kuwatsuka, Y.
    Iwanaga, M.
    Niino, D.
    Murota, H.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (09) : S238 - S238
  • [28] Programmed death-1 (PD-1) and programmed death-ligand 1 (PD-L1) expressions in type 2 endometrial cancer
    Umran Kucukgoz Gulec
    Emine Kilic Bagir
    Semra Paydas
    Ahmet Baris Guzel
    Derya Gumurdulu
    Mehmet Ali Vardar
    Archives of Gynecology and Obstetrics, 2019, 300 : 377 - 382
  • [29] Outcomes and Toxicities of Programmed Death-1 (PD-1) Inhibitors in Hodgkin Lymphoma Patients in the United States: A Real-World, Multicenter Retrospective Analysis
    Bair, Steven M.
    Strelec, Lauren E.
    Feldman, Tatyana A.
    Ahmed, Gulrayz
    Armand, Philippe
    Shah, Nirav N.
    Singavi, Arun N.
    Reddy, Nishitha
    Khan, Nadia
    Andreadis, Charalambos
    Khoan Vu
    Huntington, Scott F.
    Giri, Smith
    Ujjanii, Chaitra
    Howlett, Christina
    Faheem, Malik
    Youngman, Matthew R.
    Nasta, Sunita D.
    Landsburg, Daniel J.
    Schuster, Stephen J.
    Svoboda, Jakub
    ONCOLOGIST, 2019, 24 (07): : 955 - 962
  • [30] Programmed Death-1 (PD-1) Receptor/PD-1 Ligand (PD-L1) Expression in Fumarate Hydratase-Deficient Renal Cell Carcinoma
    Alaghehbandan, Reza
    Stehlik, Jan
    Trpkov, Kiril
    Magi-Galluzzi, Cristina
    Foix, Maria Pane
    Berney, Daniel
    Sibony, Mathilde
    Suster, Saul
    Agaimy, Abbas
    Montiel, Delia Perez
    Pivovarcikova, Kristyna
    Michalova, Kvetoslava
    Daum, Ondrej
    Ondic, Ondrej
    Rotterova, Pavla
    Michal, Michal
    Hes, Ondrej
    LABORATORY INVESTIGATION, 2017, 97 : 211A - 211A
12345